AI assistant
Sending…
Celldex Therapeutics, Inc. — Director's Dealing 2009
Nov 30, 2009
31801_dirs_2009-11-30_2a2e81f4-d0e5-4736-9d98-b2a5e82c2de2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2009-11-30
Reporting Person: ELLBERGER LARRY (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-11-30 | Common Stock | P | 300 | $4.46 | Acquired | 300 | Direct |
| 2009-11-30 | Common Stock | P | 3300 | $4.47 | Acquired | 3300 | Direct |
| 2009-11-30 | Common Stock | P | 1400 | $4.48 | Acquired | 1400 | Direct |
More from Celldex Therapeutics, Inc.
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Apr 1
Major Shareholding Notification
2026
Mar 26